THE PLATELET SOCIETY
To advance the education of the public and to promote and assist research in all matters associated with Platelets in disease and to ensure the dissemination of the useful results of such research.
Financial health, per its FY2025 accounts
The accounts state that the charity held unrestricted reserves of £32,437.78 after committing £19,434.34 to legacy fund initiatives, resulting in a net profit of £2,189.80 for the year. The trustees report that the society remains sustainable in the short-to-medium term, though they note that further diversification of income will likely be required to maintain this position in the longer term due to rising costs.
What the accounts disclose
“Membership income has increased this year (£5403, up from £3533 in 2023-24).” — page 8
Register events
- Received assets from another charity (07/10/2017)
Trustees
- Professor Alison Helena Goodallchair
- Dr Ronald James
- John Crispian Strachan CBE, QPM
- Professor Adrian Charles Newland
- Professor Timothy David Warner
- Robert George Humphries
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £42k | £40k |
| 31/07/2024 | £52k | £83k |
| 30/06/2023 | £62k | £48k |
| 30/06/2022 | £58k | £19k |
| 30/06/2021 | £18k | £23k |
Common questions
Is THE PLATELET SOCIETY financially healthy?
Per its FY2025 accounts: The accounts state that the charity held unrestricted reserves of £32,437.78 after committing £19,434.34 to legacy fund initiatives, resulting in a net profit of £2,189.80 for the year. The trustees report that the society remains sustainable in the short-to-medium term, though they note that further diversification of income will likely be required to maintain this position in the longer term due to rising costs. Its FY2025 accounts were independently examined.